Session Details
[D1-A4]EBF Activities for the Future of Bioanalysis
Mon. Mar 3, 2025 5:00 PM - 5:30 PM JST
Mon. Mar 3, 2025 8:00 AM - 8:30 AM UTC
Mon. Mar 3, 2025 8:00 AM - 8:30 AM UTC
Medium Hall(2nd Floor)
Chairman:Takashi Miyayama(Chugai Pharmaceutical Co., Ltd.), Hisanori Hara(B2S Life Sciences)
[D1-A4-01]Our Challenges for the Future – A Perspective from the EBF
*Philip Timmerman1 (1. European Bioanalysis Forum)